Reduction in the number of thromboxane receptors on human platelets after exposure to GR32191.

about

Characteristics of the binding of [3H]-GR32191 to the thromboxane (TP-) receptor of human platelets Differential mapping of the amino acids mediating agonist and antagonist coordination with the human thromboxane A2 receptor protein.

P2860

Q28378365-F4F92EE0-3C23-475B-BE1C-36A4F5442104 Q40256331-89A0985A-BBDB-4BE6-BACE-80D2B00DFA1F

P2860

Reduction in the number of thromboxane receptors on human platelets after exposure to GR32191.

Item

http://www.wikidata.org/entity/Q42920819

description

1993 nî lūn-bûn

@nan

1993年の論文

@ja

1993年論文

@yue

1993年論文

@zh-hant

1993年論文

@zh-hk

1993年論文

@zh-mo

1993年論文

@zh-tw

1993年论文

@wuu

1993年论文

@zh

1993年论文

@zh-cn

name

Reduction in the number of thr ...... ets after exposure to GR32191.

@en

Reduction in the number of thr ...... ets after exposure to GR32191.

@nl

type

Item

label

Reduction in the number of thr ...... ets after exposure to GR32191.

@en

Reduction in the number of thr ...... ets after exposure to GR32191.

@nl

prefLabel

Reduction in the number of thr ...... ets after exposure to GR32191.

@en

Reduction in the number of thr ...... ets after exposure to GR32191.

@nl

P1476

Reduction in the number of thr ...... ets after exposure to GR32191.

@en

P2093

Armstrong RA

http://www.w3.org/2001/XMLSchema#string

Humphrey PP

http://www.w3.org/2001/XMLSchema#string

Lumley P

http://www.w3.org/2001/XMLSchema#string

P2860

GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro

Characteristics of the binding of [3H]-GR32191 to the thromboxane (TP-) receptor of human platelets

Regulation of thromboxane receptor activation in human platelets

Vasopressin receptor-mediated endocytosis: current view.

Novel antihypertensive drug reveals unexpected complexities in beta-adrenoceptor pharmacology.

Agonist-induced desensitization of the beta-adrenergic receptor-linked adenylate cyclase.

Characterization of [5,6-3H]SQ 29,548 as a high affinity radioligand, binding to thromboxane A2/prostaglandin H2-receptors in human platelets.

Competitive antagonism at thromboxane receptors in human platelets.

2-substituted indazolinones: orally active and selective 5-lipoxygenase inhibitors with anti-inflammatory activity.

Characterization of U46619 binding in unactivated, intact human platelets and determination of binding site affinities of four TXA2/PGH2 receptor antagonists (13-APA, BM 13.177, ONO 3708 and SQ 29,548).

P304

548-552

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1476-5381.1993.TB13845.X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P577

1993-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14957519

http://www.w3.org/2001/XMLSchema#string

P698

8242229

http://www.w3.org/2001/XMLSchema#string

P932

2175917

http://www.w3.org/2001/XMLSchema#string

Reduction in the number of thromboxane receptors on human platelets after exposure to GR32191.

about

P2860

P2860

Reduction in the number of thromboxane receptors on human platelets after exposure to GR32191.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932